Could Retirement Harm Your Brain? You’ve worked decades toward retirement, and it is finally here. You look forward to the unhurried schedule, traveling, and more time with family. But could retirement also be a risk factor for dementia? As rates of Alzheimer’s disease and other dementias have increased over the past several decades, researchers have…
Details
In 1906, Dr. Alois Alzheimer performed a brain autopsy on one of his recently deceased patients, Auguste Deter (55 years old), who had suffered for years with a rapid decline in memory, an inability to care for herself, and recurrent delusions. During that autopsy, Dr. Alzheimer identified changes within the brain that he attributed to…
Details
Last week, I reviewed the 2026 WHO Guidelines for Dementia Prevention, a 140-page document that suggests up to 45% of dementia risk may be preventable. In that review, I distilled dementia prevention down to three core principles: Those are important foundations. But this week, I want to highlight several areas where I believe the WHO…
Details
Nearly 10 million people develop dementia each year, and more than 57 million people worldwide are currently living with dementia. Alzheimer’s disease is the most common form of dementia, accounting for an estimated 60–70% of cases. In the United States, Alzheimer’s disease was the sixth-leading cause of death in 2024. But there is also encouraging…
Details
We’re continuing our series on some of the most popular peptides out there—the pros, the cons, what the evidence (if any!) says, and our in-house practical advice on using targeted peptides as part of your health journey. This review comes at an interesting time. In July 2026, the FDA’s Pharmacy Compounding Advisory Committee considered Semax…
Details
What if a simple blood test could help detect signals associated with more than 50 types of cancer — even before symptoms appear? Multi-cancer early detection (MCED) testing is an emerging approach to cancer screening that could change the way we identify cancer in its earliest stages. At Authentic Health in Asheville, we’re excited about…
Details
MOTS-c Explained: The Mitochondrial Peptide for Energy, Metabolism, and Healthy Aging We are continuing our series on some of the most popular peptides out there—the pros, the cons, what the evidence (if any!) says, and our in-house practical advice on using targeted peptides as part of your health journey. This review comes at an interesting…
Details
Did you know that you can have a normal fasting glucose or a normal A1c and still have a problem managing blood sugar? Medicine is ruled by cut-offs. We need them for diagnosis, for billing, for medication choices, for tracking over time. The American Diabetes Association has created definitions for insulin resistance in a variety…
Details
We are back reviewing the most popular peptides out there — the pros, the cons, what the evidence (if any!) say, and our in-house practical advice on using targeted peptides for your health journey. This review comes at an interesting time as the FDA recently cleared the way for these peptides to be made by…
Details
We’re back with another review of one of the most talked-about peptides in the world of regenerative and longevity medicine. In this series, we explore the science, potential benefits, limitations, and practical applications of targeted peptides for health optimization. Today, we’re taking a closer look at TB-500, also known as Thymosin Beta-4 (TB4), a peptide…
Details
